The purpose of this review is to instead focus on the role of EZH2 in CD8+ T cell differentiation and effector function in the context of viral infection and cancer, comparing and contrasting phenotypes observed across multiple models to give greater insight into EZH2 biology. Here, CD8A is linked to cancer.